Literature DB >> 10446855

Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues.

R A Dodds1, J R Connor, F H Drake, M Gowen.   

Abstract

OBJECTIVE: To investigate the expression of cathepsin K messenger RNA (mRNA) in the giant cells found in human osteoarthritic (OA) synovium and associated reparative connective tissues, and to compare this with mRNA expression of cathepsins B, L, and S, which are cysteine proteases known to be highly expressed by cells of the monocyte/macrophage lineage.
METHODS: Sections of human OA synovium were processed for in situ hybridization and probed for cathepsins K, B, L, and S. Serial sections were reacted for tartrate-resistant acid phosphatase (TRAP) and nonspecific esterase (NSE) activity, which are selective markers for the osteoclast and cells of the macrophage/monocyte lineage, respectively.
RESULTS: At 3 sites of monocyte infiltration/giant cell formation (granulation tissue, the intimal and subintimal synovial layers, and deep stroma extending to the periphery of osteophytic tissue), both TRAP-positive mono- and multinucleated cells and TRAP-negative, NSE-positive mononuclear precursors were identified. Cells containing both enzyme activities were also found, potentially indicating an intermediate stage of differentiation. The TRAP-positive mononuclear/giant cells, and the occasional NSE-positive precursor, expressed an intense signal for cathepsin K mRNA, but did not express cathepsins B, L, and S. In contrast, the deep zone of phagocytic-like cells adjacent to sites of ossification expressed high levels of mRNA for cathepsins L, B, and S as well as cathepsin K mRNA.
CONCLUSION: Giant cells that form within OA synovial tissue express high levels of cathepsin K mRNA. It appears that cathepsin K acts principally to digest the bone (and cartilage) fragments sheered from the joint surface during OA. The high TRAP activity and the undetectable expression of the macrophage-associated degradative proteases (cathepsins B, L, and S) by synovial giant cells strengthens the hypothesis that cathepsin K is the primary protease involved in bone degradation. At sites of synovial osteogenesis, a population of phagocytic-like cells expressed TRAP and cathepsins B, L, S, and K, and may represent blood-derived macrophages pushed toward an osteoclast phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446855     DOI: 10.1002/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis.

Authors:  Wei-Ping Chen; Jia-Peng Bao; Jin-Li Tang; Peng-Fei Hu; Li-Dong Wu
Journal:  Rheumatol Int       Date:  2011-10       Impact factor: 2.631

2.  Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation.

Authors:  W S Hou; Z Li; R E Gordon; K Chan; M J Klein; R Levy; M Keysser; G Keyszer; D Brömme
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis.

Authors:  J P Morko; M Söderström; A-M K Säämänen; H J Salminen; E I Vuorio
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

4.  Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.

Authors:  Izabela Podgorski; Bruce E Linebaugh; Jennifer E Koblinski; Deborah L Rudy; Mackenzie K Herroon; Mary B Olive; Bonnie F Sloane
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

5.  The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases.

Authors:  Jean-Pierre Pelletier; Christelle Boileau; Martin Boily; Julie Brunet; François Mineau; Changshen Geng; Pascal Reboul; Stefan Laufer; Daniel Lajeunesse; Johanne Martel-Pelletier
Journal:  Arthritis Res Ther       Date:  2005-07-19       Impact factor: 5.156

6.  Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.

Authors:  A Punturieri; S Filippov; E Allen; I Caras; R Murray; V Reddy; S J Weiss
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

7.  High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis.

Authors:  Reuben Gobezie; Alvin Kho; Bryan Krastins; David A Sarracino; Thomas S Thornhill; Michael Chase; Peter J Millett; David M Lee
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 8.  Articular cartilage and changes in arthritis: matrix degradation.

Authors:  J S Mort; C J Billington
Journal:  Arthritis Res       Date:  2001-09-06

9.  Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores.

Authors:  Marcella Funicello; Michela Novelli; Maurizio Ragni; Teresa Vottari; Cesare Cocuzza; Joaquin Soriano-Lopez; Chiara Chiellini; Federico Boschi; Pasquina Marzola; Pellegrino Masiello; Paul Saftig; Ferruccio Santini; Rene St-Jacques; Sylvie Desmarais; Nicolas Morin; Joseph Mancini; M David Percival; Aldo Pinchera; Margherita Maffei
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

10.  Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711.

Authors:  Erik Lindström; Biljana Rizoska; Ian Henderson; Ylva Terelius; Markus Jerling; Charlotte Edenius; Urszula Grabowska
Journal:  J Transl Med       Date:  2018-05-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.